100 related articles for article (PubMed ID: 2557673)
1. [Effects of kappa-opiate receptor antagonist MR-2266-BS on ACTH and prolactin release].
Xu RK; Chen L; Li H; Yang SJ; Huang XY
Sheng Li Xue Bao; 1989 Aug; 41(4):395-401. PubMed ID: 2557673
[TBL] [Abstract][Full Text] [Related]
2. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
3. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
[TBL] [Abstract][Full Text] [Related]
4. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
[TBL] [Abstract][Full Text] [Related]
5. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
[TBL] [Abstract][Full Text] [Related]
6. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
[TBL] [Abstract][Full Text] [Related]
7. Opiate receptor subtypes in the regulation of thyrotropin and prolactin secretion in the rat.
Rauhala P; Tuominen RK; Männistö PT
Horm Res; 1988; 29(5-6):218-22. PubMed ID: 2851523
[TBL] [Abstract][Full Text] [Related]
8. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of naloxone on basal and stress-induced release of ACTH and prolactin in the male rat.
Xu RK; McCann SM
Life Sci; 1989; 45(17):1591-9. PubMed ID: 2555640
[TBL] [Abstract][Full Text] [Related]
10. Different control of the adrenocorticotropin-corticosterone response and of prolactin secretion during cold stress, anesthesia, surgery, and nicotine injection in the rat: involvement of capsaicin-sensitive sensory neurons.
Donnerer J; Lembeck F
Endocrinology; 1990 Feb; 126(2):921-6. PubMed ID: 2153534
[TBL] [Abstract][Full Text] [Related]
11. [Role of central endogenous dynorphin in control of ACTH and prolactin release during resting and stress].
Xu RK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):178-81. PubMed ID: 1981865
[TBL] [Abstract][Full Text] [Related]
12. [Activation of delta-opiate receptor simultaneously stimulates ACTH beta-endorphin and prolactin release].
Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Apr; 14(2):105-9. PubMed ID: 1319850
[TBL] [Abstract][Full Text] [Related]
13. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
Panerai AE; Martini A; Sacerdote P; Mantegazza P
Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
[TBL] [Abstract][Full Text] [Related]
14. ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.
Poggioli R; Vergoni AV; Bertolini A
Peptides; 1986; 7(5):843-8. PubMed ID: 3025825
[TBL] [Abstract][Full Text] [Related]
15. Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat.
Petraglia F; Vale W; Rivier C
Neuroendocrinology; 1987 May; 45(5):338-42. PubMed ID: 2884585
[TBL] [Abstract][Full Text] [Related]
16. The effects of the selective kappa-opioid agonist MR 2034 on the guinea-pig ileum.
Coupar JM; Quinn MJ
J Pharm Pharmacol; 1988 May; 40(5):378-80. PubMed ID: 2899640
[TBL] [Abstract][Full Text] [Related]
17. Involvement of oxytocin in histamine- and stress-induced ACTH and prolactin secretion.
Kjaer A; Knigge U; Warberg J
Neuroendocrinology; 1995 Jun; 61(6):704-13. PubMed ID: 7659194
[TBL] [Abstract][Full Text] [Related]
18. Effects of the kappa opioid receptor antagonist MR-2266-BS on the acquisition of ethanol preference.
Sandi C; Borrell J; Guaza C
Life Sci; 1990; 46(16):1119-29. PubMed ID: 2160572
[TBL] [Abstract][Full Text] [Related]
19. Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.
Panerai AE; Petraglia F; Sacerdote P; Genazzani AR
Endocrinology; 1985 Sep; 117(3):1096-9. PubMed ID: 2990867
[TBL] [Abstract][Full Text] [Related]
20. N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesic.
Wood PL
Neuropeptides; 1985 Feb; 5(4-6):323-6. PubMed ID: 2987733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
